GMP ORPHAN DRUGS FOR ORPHAN DISEASES

What this means for you

Registered since 03 Jun 2014. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79134010

Registration number

4541221

Mark type

Design + words

Filed

14 May 2013

Published for opposition

18 Mar 2014

Registered

03 Jun 2014

Attorney of record

Heather Smith-Carra

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products for the treatment of orphan diseases; medication for the treatment of orphan diseases; pharmaceutical and veterinary products for pediatric use for the treatment of orphan diseases; medication for pediatric use for the treatment of orphan diseases; chemical preparations for medical or pharmaceutical use in the treatment of childhood diseases; pharmaceutical and veterinary products and medicines for the treatment of orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy; pharmaceutical and veterinary products and medicines for the treatment of hyperammonemia of all kinds
• Class 010 — Medical apparatus: [ Medical, surgical and veterinary apparatus and instruments, for diagnosis and treatment, particularly in connection with orphan diseases; medical devices containing chemical products for diagnostic use of orphan diseases; medical diagnosis apparatus and instruments to diagnose orphan diseases; automatic testing apparatus to diagnose orphan diseases, for medical use, also in the form of kits; medical apparatus and instruments in the form of kits for detecting the presence of analytes in biological fluids, other fluids and other structures; immunochemical testing apparatus for medical use; blood testing apparatus; radiological apparatus for medical use; resuscitation apparatus; medical imaging apparatus incorporating medical imaging software; needles for medical use; gloves for medical use; syringes for medical use; inhalers for medical purposes; injectors for medical use; X-ray photographs for medical use; radiology screens for medical use; receptacles for applying medicines; containers especially made for medical waste; probes for medical use; stethoscopes; heart pacemakers; thermometers for medical use; cases fitted for medical instruments for use by surgeons or doctors ]
• Class 042 — Scientific and technological services: Evaluations, assessments and research in the fields of science; research and development services in the field of medicine; research and development of new products for others, namely, medical diagnosis apparatus; research and development in the field of biotechnology; scientific research for medical purposes; scientific laboratory services in the medical field; all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy
• Class 044 — Medical, beauty and agricultural services: Medical services; medical and sanitary care, namely, telemedecine services including remote diagnosis or medical follow-up; medical testing for the diagnosis and treatment of persons; providing medical advice on health matters in the field of medication administration; providing medical advisory services relating to medical apparatus and instruments; medical diagnosis services of orphan diseases; providing medical information, all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy

Owner

• ORPHALAN, FR
• GMP-ORPHAN, FR
• GMP-ORPHAN, FR

Prosecution history

• 06 Mar 2026 — CANCELLED SECTION 71
• 09 Jun 2023 — INTERNATIONAL REGISTRATION RENEWED
• 03 Jun 2023 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
• 05 Dec 2021 — PARTIAL INVALIDATION PROCESSED BY THE IB
• 27 Oct 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
• 27 Oct 2021 — INVALIDATION PROCESSED
• 06 Oct 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
• 06 Feb 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
• 06 Feb 2021 — REGISTERED - PARTIAL SEC 71 ACCEPTED
• 01 Feb 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 29 Jan 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
• 03 Dec 2020 — TEAS SECTION 71 RECEIVED
• 03 Jun 2019 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
• 07 Feb 2019 — NEW REPRESENTATIVE AT IB RECEIVED
• 08 Feb 2018 — CHANGE OF NAME/ADDRESS REC'D FROM IB